Larvol Delta

ASP2408 - Astellas

(-) Financial results for 2Q/FY 2013 ending March 31, 2014 (Astellas Press Release) - Nov 1, 2013 - ASP2408 discontinued in rheumatoid arthritis due to strategic reasons.
Discontinued • Immunology • Rheumatoid Arthritis

http://www.astellas.com/en/ir/library/pdf/2q2014_pre_en.pdf

Nov 1, 2013